Litigation, Debt, And Decline - Yet Bayer Seems Like A Buy

Core Insights - Bayer Aktiengesellschaft has not been a strong investment over the past few years, indicating potential challenges in its market performance [1] Group 1: Company Overview - Bayer is a German pharmaceutical and life science company, focusing on high-quality companies that can outperform the market due to competitive advantages and defensibility [1] Group 2: Analyst Background - The analysis is conducted by an individual with a Master's Degree in Sociology, emphasizing organizational and economic sociology, and a Bachelor's Degree in Sociology and History [1]